Correlation Between Balanced Fund and Biotechnology Ultrasector

Can any of the company-specific risk be diversified away by investing in both Balanced Fund and Biotechnology Ultrasector at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Balanced Fund and Biotechnology Ultrasector into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Balanced Fund Institutional and Biotechnology Ultrasector Profund, you can compare the effects of market volatilities on Balanced Fund and Biotechnology Ultrasector and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Balanced Fund with a short position of Biotechnology Ultrasector. Check out your portfolio center. Please also check ongoing floating volatility patterns of Balanced Fund and Biotechnology Ultrasector.

Diversification Opportunities for Balanced Fund and Biotechnology Ultrasector

-0.04

Correlation Coefficient

Balanced Fund  Biotechnology Ultrasector

Good diversification

The 3 months correlation between Balanced and Biotechnology is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Balanced Fund Institutional and Biotechnology Ultrasector Prof in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotechnology Ultrasector and Balanced Fund is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Balanced Fund Institutional are associated (or correlated) with Biotechnology Ultrasector. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotechnology Ultrasector has no effect on the direction of Balanced Fund i.e., Balanced Fund and Biotechnology Ultrasector go up and down completely randomly.

Pair Corralation between Balanced Fund and Biotechnology Ultrasector

Assuming the 90 days horizon Balanced Fund is expected to generate 1.57 times less return on investment than Biotechnology Ultrasector. But when comparing it to its historical volatility, Balanced Fund Institutional is 4.88 times less risky than Biotechnology Ultrasector. It trades about 0.1 of its potential returns per unit of risk. Biotechnology Ultrasector Profund is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  5,620  in Biotechnology Ultrasector Profund on September 12, 2024 and sell it today you would earn a total of  995.00  from holding Biotechnology Ultrasector Profund or generate 17.7% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	99.7%
Values	Daily Returns

Balanced Fund Institutional  vs.  Biotechnology Ultrasector Prof

Balanced Fund Instit

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Balanced Fund Institutional are ranked lower than 12 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong basic indicators, Balanced Fund is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Biotechnology Ultrasector

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Biotechnology Ultrasector Profund has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong forward indicators, Biotechnology Ultrasector is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Balanced Fund and Biotechnology Ultrasector

The main advantage of trading using opposite Balanced Fund and Biotechnology Ultrasector positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Balanced Fund position performs unexpectedly, Biotechnology Ultrasector can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotechnology Ultrasector will offset losses from the drop in Biotechnology Ultrasector's long position.

The idea behind Balanced Fund Institutional and Biotechnology Ultrasector Profund pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.